What Changes are in Store for the Cancer Drug Fund?

The National Institute for Health and Care Excellence (NICE) and the National Health Service (NHS) England have proposed changes to the operation of the Cancer Drugs Funds. Why does the fund need reform and what will that reform look like? See more here. (Source: Pharmafile, 1/14/16)

You might also be interested in:

NICE Chief Dillon to Exit in 2020 August 24, 2019
NICE Report: Cancer Drugs Priced According to Effectiveness… February 25, 2019
NICE Post Reflects on Partnership with CMAC September 18, 2019
NICE Releases Cancer, Non-Cancer TA Data September 23, 2019
ICER Unveils Proposed Changes to Value Assessment Framework August 22, 2019
Report: NHS Patient Data Could be Worth Billions July 25, 2019
NICE to Review Guidance Development Protocol July 26, 2019